Related Experiment Video
Updated: Aug 19, 2026

Assessing Anti-fungal Activity of Isolated Alveolar Macrophages by Confocal Microscopy
Published on: July 9, 2014
Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear
Cristina Gil-Lamaignere1, Maria Simitsopoulou, Emmanuel Roilides
1Third Department of Pediatrics, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.
Abstract:
Zygomycetes cause serious invasive infections, predominantly in immunocompromised and diabetic patients with poor prognoses and limited therapeutic options. We compared the antifungal function of human polymorphonuclear leukocytes (PMNLs) against hyphae of Rhizopus oryzae and R. microsporus, the most frequently isolated zygomycetes, with that against the less frequently isolated Absidia corymbifera. We then evaluated the effects of interferon (IFN)- gamma and granulocyte-macrophage colony-stimulating factor (GM-CSF), alone or combined, on PMNL antifungal function against these zygomycetes. Both PMNL oxidative burst in response to hyphae and PMNL-induced hyphal damage were significantly lower in response to Rhizopus species than in response to A. corymbifera. Incubation of PMNLs with IFN- gamma and GM-CSF alone or combined for 22 h increased the PMNL-induced hyphal damage of all 3 species. The treatment of PMNLs with the combination of IFN- gamma and GM-CSF significantly increased the release of tumor necrosis factor- alpha in response to R. microsporus and A. corymbifera hyphae. IFN- gamma significantly reduced interleukin-8 release in response to all zygomycetes. Although Rhizopus species demonstrate a decreased susceptibility to the antifungal activity of human PMNLs, in comparison with A. corymbifera, IFN- gamma and GM-CSF augment the hyphal damage of all 3 zygomycetes, suggesting a role for IFN- gamma and GM-CSF in the management of invasive zygomycosis.
Insights
Human immune cells show reduced antifungal activity against Rhizopus species. However, interferon-gamma and GM-CSF enhance immune cell function, suggesting potential therapeutic benefits for invasive zygomycosis.
Area of Science:
- Mycology
- Immunology
- Infectious Diseases
Background:
- Zygomycetes cause severe invasive infections, particularly in immunocompromised and diabetic individuals.
- Limited therapeutic options exist for invasive zygomycosis, highlighting the need for novel treatment strategies.
Purpose of the Study:
- To compare the antifungal function of human polymorphonuclear leukocytes (PMNLs) against Rhizopus oryzae, Rhizopus microsporus, and Absidia corymbifera.
- To evaluate the effects of interferon-gamma (IFN-γ) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on PMNL antifungal activity against these zygomycetes.
Main Methods:
- Compared PMNL oxidative burst and hyphal damage against three zygomycete species.
- Assessed the impact of IFN-γ and GM-CSF, alone and combined, on PMNL function.
- Measured cytokine release (TNF-α, IL-8) following PMNL-cytokine treatment and zygomycete exposure.
Main Results:
- PMNLs exhibited significantly lower antifungal activity against Rhizopus species compared to A. corymbifera.
- Incubation with IFN-γ and/or GM-CSF enhanced PMNL-induced hyphal damage against all three zygomycete species.
- Combined IFN-γ and GM-CSF treatment increased TNF-α release and decreased IL-8 release.
Conclusions:
- Rhizopus species are less susceptible to human PMNLs than A. corymbifera.
- IFN-γ and GM-CSF can augment PMNL-mediated hyphal damage, indicating their potential role in managing invasive zygomycosis.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Viral Protein Synthesis
Antifungal Agents
Fungal Group Zygomycota
Cryptococcal Meningitis

